Acetazolamide is a synthetic carbonic anhydrase inhibitor used primarily for ophthalmic conditions and altitude sickness. It blocks the enzyme carbonic anhydrase in the eye and kidneys, decreasing fluid production. This reduction in fluid lowers intraocular pressure and facilitates fluid elimination. By decreasing bicarbonate formation, the drug promotes diuresis and reduces systemic edema. The pharmacological effect stems from inhibition of carbonic anhydrase in the ciliary body and renal tubules. The resulting decrease in ocular pressure and altered renal ion transport underlies its therapeutic use.

Acetazolamide is a synthetic carbonic anhydrase inhibitor that is used clinically to reduce intraocular pressure and treat certain types of glaucoma. It works by decreasing the production of aqueous humor in the eye, thereby lowering pressure within the ocular cavity. This inhibition also reduces the activity of carbonic anhydrase in the kidneys, leading to increased excretion of bicarbonate and a mild diuretic effect. The lowered intraocular pressure improves ocular blood flow and helps preserve visual function in patients with glaucoma. Clinically, Acetazolamide is also employed to prevent and treat altitude sickness by accelerating acclimatization through enhanced ventilation and metabolic adjustments. Its pharmacologic action therefore combines antidiuretic, alkalizing, and ocular hypotensive properties that collectively produce its therapeutic outcomes.

Acetazolamide is a carbonic anhydrase inhibitor often used to treat glaucoma. It may cause a metallic taste in the mouth. Some people experience tingling sensations in the hands or feet. Frequent urination can lead to dehydration if fluid intake is insufficient. The drug can increase the acidity of the blood, potentially causing mild metabolic acidosis. Skin rashes or itching may develop as an allergic reaction. In rare cases, visual disturbances such as blurred vision have been reported. Elevated potassium levels are uncommon but can affect heart rhythm.

Acetazolamide can cause tingling or numbness in the extremities. It may lead to frequent urination which can result in dehydration. Some people experience a metallic taste in the mouth. The medication can increase the amount of potassium excreted by the kidneys. Dizziness or lightheadedness may occur, especially when standing up quickly. Visual disturbances such as blurred vision have been reported. Skin reactions including rash or itching can develop. In rare cases, metabolic acidosis may be observed.